- Filed
- Nov 22, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Nov 17, 2021 | 100.07M sh |
| Operating Cash Flow | Q2 2021 · Sep 30, 2021 | −$36.8K |
| Operating Cash Flow | Q2 2021 · Sep 30, 2020 | −$138.14K |
| Total Liabilities | Q2 2021 · Sep 30, 2021 | $50.65K |
| Total Liabilities | Q2 2021 · Mar 31, 2021 | $19.5K |
| Current Assets | Q2 2021 · Sep 30, 2021 | $1.58K |
| Current Assets | Q2 2021 · Mar 31, 2021 | $10.88K |
| Total Assets | Q2 2021 · Sep 30, 2021 | $1.58K |
| Total Assets | Q2 2021 · Mar 31, 2021 | $10.88K |
| Capex | Q2 2021 · Sep 30, 2020 | $107.3K |
| Cash And Equivalents | Q2 2021 · Sep 30, 2020 | $5.64K |
| Cash And Equivalents | Q2 2021 · Mar 31, 2020 | $1.04K |
| Stockholders Equity | Q2 2021 · Sep 30, 2020 | $58.55K |
| Stockholders Equity | Q2 2021 · Jun 30, 2020 | $138.93K |
| Stockholders Equity | Q2 2021 · Mar 31, 2020 | $202.06K |
| Sga Expense restated | Q2 2021 · Sep 30, 2020 | $31.67K |
| Sga Expense restated | Q2 2021 · Sep 30, 2020 | $49.28K |
| Net Income restated | Q2 2021 · Sep 30, 2020 | −$63.52K |
| Net Income restated | Q2 2021 · Sep 30, 2020 | −$105.83K |
| Net Income | Q2 2021 · Jun 30, 2020 | −$42.31K |